Non-high-density lipoprotein cholesterol (non-HDL-C) and the ratio of total cholesterol to HDL-C are as good as or better than apolipoprotein fractions at predicting future cardiovascular events, according to the results of a prospective study of more than 15,000 women 45 years of age or older from the Women's Health Study.
Non-high-density lipoprotein cholesterol (non-HDL-C) and the ratio of total cholesterol to HDL-C are as good as or better than apolipoprotein fractions at predicting future cardiovascular events, according to the results of a prospective study of more than 15,000 women 45 years of age or older from the Women's Health Study.
The study directly compared non-HDL-C, apolipoproteins B100 and A-1, standard lipid measures, lipid ratios, and high-sensitivity C-reactive protein (CRP) as predictors of cardiovascular health. The researchers found that while the magnitude of the association was greater for apolipoprotein B100 than for either total cholesterol or LDL-C, apolipoprotein B100 was highly correlated with non-HDL-C. Since non-HDL-C can be calculated by subtracting HDL-C from total cholesterol at no additional cost, it makes more sense for primary care risk assessment purposes.
In addition, they found that the easily calculated ratio of total cholesterol to HDL-C was equally associated with cardiovascular events as the ratio of apolipoprotein B100 to apolipoprotein A-1.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More